Research Article | Open Access
Volume 4 | Issue 7 | Year 2017 | Article Id. IJMS-V4I7P101 | DOI : https://doi.org/10.14445/23939117/IJMS-V4I7P101Screening of hemoglobinopathies in 32000 dried blood spot samples by cation exchange high performance liquid chromatography - An Indian study
Mahesh H Hampe, Shrimant N Panaskar, Mr. Rajan Mestri, Ms. Neha A Kamble, Ms. Pallavi S. Chaudhari, Ashwini A Yadav, Pramod W Ingale and Babu Kandasamy
Citation :
Mahesh H Hampe, Shrimant N Panaskar, Mr. Rajan Mestri, Ms. Neha A Kamble, Ms. Pallavi S. Chaudhari, Ashwini A Yadav, Pramod W Ingale and Babu Kandasamy, "Screening of hemoglobinopathies in 32000 dried blood spot samples by cation exchange high performance liquid chromatography - An Indian study," International Journal of Medical Science, vol. 4, no. 7, pp. 1-7, 2017. Crossref, https://doi.org/10.14445/23939117/IJMS-V4I7P101
Abstract
Background & objectives:The present study evaluated usefulness of cation exchange highperformance liquid chromatography (HPLC) as a screening tool for early detection of thalassemia & hemoglobin variants in dried blood spot (DBS) samples. We discussed the laboratory aspects ofdiagnostic difficulties in HPLC based screening algorithm in Indian population.Methods:-A total of 32000 DBS samples collected from neonates were primarily screened for hemoglobinopathies on HPLC between June 2013 and May 2016. All presumptive abnormal profiles were re-tested on HPLC after 6 months of age. The follow up results were correlated with parental studies and additional investigations for confirmation.Results: Totally 982 samples (3.06%) showed abnormal HPLC pattern on primary neonatal screening. In follow up testing of 914 presumptive abnormal cases, 583 (1.82%) cases have been confirmed for variant hemoglobin’s. Sickle variant was the commonest hemoglobinopathy found in 156 (26.7%) cases. HbE (21.4%), β-thalassemia (19.5%) and HbD (19.5%) disorders being the next common variants. HPLC alone diagnosed more than 85% cases with abnormal variants. Interpretation &Conclusions: Analysis of DBS samples on HPLC is a convenient primary tool for hemoglobin variant screening for hemoglobinopathies. Our study enabled us to design a practical flow chart for large scale HPLC based screening of major hemoglobinopathies with judicious requirement of investigations on other platforms.
Keywords
High performance liquid chromatography (HPLC), dried blood spot (DBS), hemoglobinopathies.
References
[1] H. Wajcman, K. Moradkhani, Abnormal hemoglobin’s: detection & characterization, Indian J Med Res. 134 (2011) 538-546.
[2] B. Hedlund, Hemoglobin’s of human embryos, fetuses, and neonates, In: Fairbanks VF, ed. Hemoglobinopathies and thalassemia’s, New York: Brian C. Decker, (1980) 14-17.
[3] G.M. Clarke, T.N. Higgins, Laboratory investigation of hemoglobinopathies and thalassemia’s: review and update, Clin Chem. 46 (2000) 1284-1290.
[4] T. Chatterjee, A. Chakravarty, S. Chakravarty, Population Screening and Prevention Strategies for Thalassemias and other Hemoglobinopathies of Eastern India, Experience of 18,166 cases, Hemoglobin. 39 (2015) 384-388.
[5] S. Iyer, S. Sakhare, C. Sengupta, A. Velumani, Hemoglobinopathy in India, Clin ChimActa. 444 (2015) 229- 233.
[6] D.J. Dietzen, P. Rinaldo, R.J. Whitley, W.J. Rhead, W.H. Hannon, National academy of clinical biochemistry laboratory medicine practice guidelines: follow-up testing for metabolic disease identified by expanded newborn screening using tandem mass spectrometry; executive summary, Clin Chem. 55 (2009) 1615-1626.
[7] B. Modell, M. Darlison, Global epidemiology of hemoglobin disorders and derived service indicators, Bull World Health Organ. 86 (2008) 480-487.
[8] A. Joutovsky, J. Hadzi-Nesic, M.A. Nardi, HPLC retention time as a diagnostic tool for hemoglobin variants and hemoglobinopathies: a study of 60000 samples in a clinical diagnostic laboratory, Clin Chem. 50 (2004) 1736-1747.
[9] D.F. Keren, D. Hedstrom, R. Gulbranson, C.N. Ou, R. Bak, Comparison of SebiaCapillarys capillary electrophoresis with the Primus high-pressure liquid chromatography in the evaluation of hemoglobinopathies, Am J Clin Pathol. 130 (2008) 824-831.
[10] J.W. Eastman, R. Wong, C.L. Liao, D.R. Morales, Automated HPLC screening of newborns for sickle cell anemia and other hemoglobinopathies, Clin Chem. 42 (1996) 704-710.
[11] C.N. Ou, C.L. Rogerud, Rapid analysis of hemoglobin variants by cation-exchange HPLC, Clin Chem. 39 (1993) 820-824.
[12] B.J. Wild, A.D. Stephens, The use of automated HPLC to detect and quantitate haemoglobins, Clin Lab Haematol. 19 (1997) 171-176.
[13] C.N. Ou, C.L. Rogerud, Diagnosis of hemoglobinopathies: electrophoresis vs. HPLC, Clin ChimActa. 313 (2001) 187- 194.
[14] J.V. Mei, J.R. Alexander, B.W. Adam, W.H. Hannon, Use of filter paper for the collection and analysis of human whole blood specimens, J Nutr. 131 (2001) 1631S-1636S.
[15] A. Giambona, C. Passarello, M. Vinciguerra, R. Li Muli, P. Teresi, M. Anza, Significance of borderline hemoglobin A2 values in an Italian population with a high prevalence of Betathalassemia, Haematologica. 93 (2008) 1380-1384.
[16] F.P. van der Dijs, G.A. van den Berg, J.G. Schermer, F.D. Muskiet, H. Landman, F.A. Muskiet, Clin Chem. 38 (1992) 1864-1869.
[17] A. Mosca, R. Paleari, D. Leone, G. Ivaldi, The relevance of hemoglobin F measurement in the diagnosis of thalassemias and related hemoglobinopathies, Clin Biochem. 18 (2009) 1797-801.
[18] M.K. Baruah, M. Saikia, A. Baruah, Pattern of hemoglobinopathies and thalassemias in upper Assam region of North Eastern India: high performance liquid chromatography studies in 9000 patients, Indian J PatholMicrobiol. 57 (2014) 236-243.
[19] R.S. Balgir, Spectrum of hemoglobinopathies in the state of Orissa, India: a ten years cohort study, J Assoc Physicians India. 53 (2005) 1021-1026.
[20] D.D. Suh, J.S. Kruss, K. Bures, Influence of hemoglobin S adducts on hemoglobin A2 quantification by HPLC, Clin Chem. 42 (1996) 113-114.
[21] P.C. Giordano, Strategies for basic laboratory diagnostics of the hemoglobinopathies in multi-ethnic societies: interpretation of results and pitfalls, Int J Lab Hematol. 35 (2013) 465-479.
[22] S.P. Parker, W.D. Cubitt, The use of the dried blood spot sample in epidemiological studies, J Clin Pathol. 52 (1999) 633-639.
[23] C. Panadea, J.R. Eckman, R.S. Kuchnert, A.F. Platt, Comparison of liquid and dried blood for neonatal hemoglobin screening: Laboratory and programmatic issues, Pediatrics. 93 (1994) 427-432.